PR
ProPhase Labs, Inc.
PRPH · OTC
$0.02 +10.71% (+$0.00)
1M -53.33%
Market Cap $196.2K
P/E Ratio -
Div. Yield -
ROE 1,358.66%
Bulios Fair Price
$0.02
29.0% upside
Trenutna cena
$0.016
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PRPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.06x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 67.16%
Book val. growth N/A
EPS growth N/A
Profitability
4 /100
Weak Op. margin 498.73%
Gross margin 16.38%
FCF margin 972.30%
Quality
1 /100
Poor ROA 39.44%
ROIC 179.88%
Asset turnover 0.05x
Debt
0 /100
High Int. coverage -2.21x
Current ratio 0.05x
Debt/Assets N/A
Stability
14 /100
Unstable EPS volatility 159.20%
Beta 0.13x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRPH
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ted William Karkus
Employees
19
Headquarters
Uniondale
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report